Just diagnosed with cancer? Slow down — the most powerful thing you can do right now… is be still.
In this deeply compassionate episode, Dr. Dino Prato, founder of Envita Medical Centers, shares the first step every patient should take after hearing the words “you have cancer.” When fear is high and time feels short, the urge to rush into treatment is strong — but reactive medicine often leads to poor results.
🎯 What You’ll Learn:

• Why mapping your cancer before treatment may lead to better outcomes
• How genomic, immune, and infection-based testing changes the game
• The role of faith, prayer, and peace of mind in your healing process
• Why most patients we see have already tried the wrong treatments — simply because they weren’t targeted
• How our published outcomes show 35x better response and 43x better quality of life using precision cancer care*

(*See Outcomes Disclaimer Below)
If you're newly diagnosed or feel lost in a sea of opinions, this video will guide you toward clarity, calm, and confidence — all through data, faith, and personalized planning.
“You don’t have to follow the crowd. You need a map — and the strength to walk your path.”

Disclaimer
This podcast is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your licensed healthcare provider before making any medical decisions. Individual results will vary, and Envita Medical Centers does not guarantee outcomes. Some treatments discussed may not be FDA-approved or available in all locations. Testimonials are shared with patient consent and may not reflect typical results. Do not delay or disregard professional medical care based on the podcast's content. Certain treatments may be available only at Envita’s international clinic in Hermosillo, Mexico. No specific outcomes are promised or implied.
________________________________________
Outcomes Disclaimer
The results referenced from Envita's Precision Cancer Care: 35-Fold Improvement in Response Rates are from a retrospective analysis of 199 late-stage cancer patients treated at Envita Medical Centers between 2021 and 2023, as published in the Journal of Cancer Therapy. These outcomes are not guaranteed and will vary based on individual factors such as cancer type, stage, genetics, immunity and prior treatments. Any comparisons to standard care or clinical trials are based on published data and internal analysis, not head-to-head studies. Individual results will vary.

You can read the full peer-reviewed study at:

https://www.scirp.org/journal/paperinformation?paperid=132493